mutations and complicated kar yotype. It follows a linear evolution within the CLL clone throughout the recurrent acquisition of CDKN2AGenetic susceptibility mechanisms. Most susceptibility loci map to non-coding regions on the genome, are predominantly located in Lively promoters or enhancers, and modify the binding web sites of many transcription